Decrease in stromal androgen receptor associates with androgen-independent disease and promotes prostate cancer cell proliferation and invasion

Journal of Cellular and Molecular Medicine

Volumn 12, Issue 6B, 2008, Pages 2790-2798

  Li, Yirong ^a   Li, Caihong X ^a   Ye, Huihui ^a   Chen, Fei ^a   Melamed, Jonathan ^a   Peng, Yi ^a   Liu, Jinsong ^b   Wang, Zhengxin ^b   Tsou, Hui C ^a   Wei, Jianjun ^a   Walden, Paul ^a   Garabedian, Michael J ^a   Lee, Peng ^a,c  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Androgen ablation; Androgen receptor; Prostate cancer; Stroma

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR; AR PROTEIN, HUMAN; TELOMERASE; TERT PROTEIN, HUMAN;

AGED; ANIMAL; ARTICLE; CANCER INVASION; CELL PROLIFERATION; CELL TRANSFORMATION; HUMAN; MALE; METABOLISM; MIDDLE AGED; MOUSE; PATHOLOGY; PROSTATE TUMOR; STROMA CELL; ULTRASTRUCTURE;

AGED; ANDROGENS; ANIMALS; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; HUMANS; MALE; MICE; MIDDLE AGED; NEOPLASM INVASIVENESS; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; STROMAL CELLS; TELOMERASE;

MUS MUSCULUS;

EID: 58149280049     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2008.00279.x     Document Type: Article

References (24)

1. Cunha GR, Hayward SW, Wang YZ. Role of stroma in carcinogenesis of the prostate. Differentiation. 2002 70 : 473 85.
2. Tuxhorn JA, Ayala GE, Rowley DR. Reactive stroma in prostate cancer progression. J Urol. 2001 166 : 2472 83
3. Edlund M, Sung SY, Chung LW. Modulation of prostate cancer growth in bone microenvironments. J Cell Biochem. 2004 91 : 686 705.
4. Condon MS. The role of the stromal microenvironment in prostate cancer. Semin Cancer Biol. 2005 15 : 132 7.
5. Hall JA, Maitland NJ, Stower M, Lang SH. Primary prostate stromal cells modulate the morphology and migration of primary prostate epithelial cells in type 1 collagen gels. Cancer Res. 2002 62 : 58 62.
6. Tomas D, Kruslin B. The potential value of (Myo)fibroblastic stromal reaction in the diagnosis of prostatic adenocarcinoma. Prostate. 2004 61 : 324 31.
7. Singh H, Dang TD, Ayala GE, Rowley DR. Transforming growth factor-beta1 induced myofibroblasts regulate LNCaP cell death. J Urol. 2004 172 : 2421 25.
8. Untergasser G, Gander R, Lilg C, Lepperdinger G, Plas E, Berger P. Profiling molecular targets of TGF-beta1 in prostate fibroblast-to-myofibroblast trans differentiation. Mech Ageing Dev. 2005 126 : 59 69.
9. Konig JJ, Romijn JC, Schroder FH. Prostatic epithelium inhibiting factor (PEIF): organ specificity and production by prostatic fibroblasts. Urol Res. 1987 15 : 145 9.
10. Kooistra A, Romijn JC, Schroder FH. Stromal inhibition of epithelial cell growth in the prostate: overview of an experimental study. Urol Res. 1997 25 : S97 105.
11. Degeorges A, Tatoud R, Fauvel-Lafeve F, Podgorniak MP, Millot G, de Cremoux P, Calvo F. Stromal cells from human benign prostate hyperplasia produce a growth-inhibitory factor for LNCaP prostate cancer cells, identified as interleukin-6. Int J Cancer. 1996 68 : 207 14.
12. Lang SH, Stower M, Maitland NJ. In vitro modelling of epithelial and stromal interactions in non-malignant and malignant prostates. Br J Cancer. 2000 82 : 990 7.
13. Kabalin JN, Peehl DM, Stamey TA. Clonal growth of human prostatic epithelial cells is stimulated by fibroblasts. Prostate. 1989 14 : 251 63.
14. Castellon E, Venegas K, Saenz L, Contreras H, Huidobro C. Secretion of prostatic specific antigen, proliferative activity and androgen response in epithelial-stromal co-cultures from human prostate carcinoma. Int J Androl. 2005 28 : 39 46.
15. Linja MJ, Visakorpi T. Alterations of androgen receptor in prostate cancer. J Steroid Biochem Mol Biol 2004 92 : 255 64.
16. Taplin ME, Balk SP. Androgen receptor: a key molecule in the progression of prostate cancer to hormone independence. J Cell Biochem. 2004 91 : 483 90.
17. Henshall SM, Quinn DI, Lee CS, Head DR, Golovsky D, Brenner PC, Delprado W, Stricker PD, Grygiel JJ, Sutherland RL. Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer. Cancer Res. 2001 61 : 423 7.
18. Olapade-Olaopa EO, MacKay EH, Taub NA, Sandhu DP, Terry TR, Habib FK. Malignant transformation of human pro-static epithelium is associated with the loss of androgen receptor immunoreactivity in the surrounding stroma. Clin Cancer Res. 1999 5 : 569 76.
19. Sidhu GS, Wieczorek R, Cassai ND, Zhu CC. The concept of bronchioloalveolar cell adenocarcinoma: redefinition, a critique of the 1999 WHO classification, and an ultra-structural analysis of 155 cases. Int J Surg Pathol. 2003 11 : 89 99.
20. Li P, Perle MA, Scholes JV, Yang GC. Wilms' tumor in adults: aspiration cytology and cytogenetics. Diagn Cytopathol. 2002 26 : 99 103.
21. Gao S, Lee P, Wang H, Gerald W, Adler M, Zhang L, Wang YF, Wang Z. The androgen receptor directly targets the cellular Fas/FasL-associated death domain protein-like inhibitory protein gene to promote the androgen-independent growth of prostate cancer cells. Mol Endocrinol. 2005 19 : 1792 802.
22. Nishimura K, Kitamura M, Miura H, Nonomura N, Takada S, Takahara S, Matsumoto K, Nakamura T, Matsumiya K. Prostate stromal cell-derived hepatocyte growth factor induces invasion of prostate cancer cell line DU145 through tumor-stromal interaction. Prostate. 1999 41 : 145 53.
23. Gao S, Wang H, Lee P, Melamed J, Li CX, Zhang F, Wu H, Zhou L, Wang Z. Androgen receptor and prostate apoptosis response factor-4 target the c-FLIP gene to determine survival and apoptosis in the prostate gland. J Mol Endocrinol. 2006 36 : 463 83.
24. Bonaccorsi L, Carloni V, Muratori M, Salvadori A, Giannini A, Carini M, Serio M, Forti G, Baldi E. Androgen receptor expression in prostate carcinoma cells suppresses alpha6beta4 integrin-mediated invasive phenotype. Endocrinology. 2000 141 : 3172 82.